(Q73832039)
Statements
The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients (English)
D E Eckhoff
B McGuire
M Sellers
J Contreras
L Frenette
C Young
S Hudson
scientific article published on 01 May 2000